LOGC

LogicBio Therapeutics Inc
2.07
0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
LogicBio Therapeutics Inc LOGC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 2.07 19:00:00
Open Price Low Price High Price Close Price Prev Close
2.07 2.07
more quote information »

Recent News

Date Time Source Heading
11/29/202216:07EDGARTermination of Registration of a Class of Security Under..
11/21/202206:03EDGARNotice of Effectiveness (effect)
11/16/202216:05EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
11/16/202216:04EDGARPost-effective Amendment to Registration Statement (pos Am)
11/16/202209:56EDGARNotification Filed by National Security Exchange to Report..
11/16/202208:30EDGARAmended Statement of Ownership: Solicitation (sc 14d9/a)
11/16/202208:21EDGARAmended Tender Offer Statement by Third Party (sc To-t/a)
11/14/202208:32EDGARQuarterly Report (10-q)
11/14/202208:11EDGARCurrent Report Filing (8-k)
11/14/202208:00PRNUSLogicBio Therapeutics Reports Third Quarter 2022 Financial..
10/20/202208:55EDGARAmended Statement of Ownership (sc 13g/a)
10/18/202216:14EDGARStatement of Ownership: Solicitation (sc 14d9)
10/18/202216:04EDGARTender Offer Statement by Third Party (sc To-t)
10/13/202216:02EDGARStatement of Ownership (sc 13g)
10/07/202216:20EDGARCurrent Report Filing (8-k)
10/03/202216:47EDGARWritten Communication Relating to an Issuer or Third Party..
10/03/202211:20DJNLogicBio Therapeutics Shares Soar on Takeover by AstraZeneca
10/03/202210:50TRMNAnalysts Offer Insights on Healthcare Companies: Clene..
10/03/202208:19TRMNAstraZeneca to Buy LogicBio Therapeutics for $2.07 Per Share
10/03/202207:57DJNAstraZeneca to Buy LogicBio Therapeutics for $68 Million
10/03/202207:15BWAlexion, AstraZeneca Rare Disease to Acquire LogicBio®..
10/03/202207:10EDGARCurrent Report Filing (8-k)
10/03/202207:00PRNUSAlexion, AstraZeneca Rare Disease to Acquire LogicBio®..
9/23/202217:28EDGARCurrent Report Filing (8-k)
9/21/202208:30PRNUSLogicBio® Therapeutics Announces Pre-Clinical Results for..
9/20/202217:16EDGARCurrent Report Filing (8-k)
8/18/202222:15TRMNLogicbio Therapeutics (LOGC) Receives a Buy from William..
8/16/202204:55TRMNJMP Securities Keeps Their Buy Rating on Logicbio..
8/15/202207:26EDGARQuarterly Report (10-q)
8/15/202207:16EDGARCurrent Report Filing (8-k)
8/15/202207:05PRNUSLogicBio Therapeutics Reports Second Quarter 2022 Financial..
6/21/202208:20EDGARStatement of Changes in Beneficial Ownership (4)
6/21/202208:16EDGARStatement of Changes in Beneficial Ownership (4)
6/21/202208:00EDGARStatement of Changes in Beneficial Ownership (4)
6/21/202207:58EDGARStatement of Changes in Beneficial Ownership (4)
6/21/202207:33EDGARCurrent Report Filing (8-k)
5/24/202205:06TRMNWilliam Blair Thinks Logicbio Therapeutics’ Stock is Going..
5/18/202207:40TRMNAnalysts Offer Insights on Healthcare Companies: Compugen..
5/18/202200:45TRMNAnalysts Offer Insights on Healthcare Companies: Aquestive..
5/17/202208:30PRNUSLogicBio® Therapeutics to Present at H.C. Wainwright Global..
5/16/202208:54EDGARSecurities Registration: Employee Benefit Plan (s-8)
5/16/202208:43EDGARQuarterly Report (10-q)
5/16/202208:30PRNUSLogicBio Therapeutics Reports First Quarter 2022 Financial..
5/11/202208:30PRNUSLogicBio Therapeutics Announces Upcoming Presentations on..
5/10/202209:15TRMNAnalysts Offer Insights on Healthcare Companies: Logicbio..
5/10/202200:47TRMNJMP Securities Thinks Logicbio Therapeutics’ Stock is Going..
5/09/202208:00PRNUSLogicBio Therapeutics Announces FDA Lifts Clinical Hold on..
5/04/202216:37EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
4/29/202208:17EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/29/202208:14EDGARProxy Statement (definitive) (def 14a)